课题基金 / 基金详情

Novel optogenetic tool for noninvasive neuronal inhibition

Novel optogenetic tool for noninvasive neuronal inhibition
用于非侵入性神经元抑制的新型光遗传学工具
批准号:
10353090
负责人:
Mark Gomelsky
金额:
$18.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-01 至 2024-06-30

项目摘要

项目成果

Mark Gomelsky的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ ABSTRACT This exploratory bioengineering project is aimed at designing, building and testing a light-activated glutamate decarboxylase (GAD) as a novel optogenetic tool for noninvasive inhibition of neuronal activity. GAD produces gamma-aminoburyric acid, GABA, a central neurotransmitter involved in reducing neuronal excitability. Enzy- matic activity of the engineered enzyme will be controlled by light in the near-infrared window (NIRW) of the spectrum (670-900 nm) that penetrates through the skull and brain tissue much better than visible light. We expect the NIRW light-activated GAD (NIRW-GAD) expressed in specific brain regions to be activated via ex- tracorporeal light (e.g., transcranially). NIRW-GAD will represent a unique optogenetic research tool for nonin- vasive, spatiotemporally controlled long-term inhibition of neuronal activity in deep or surface brain regions. In the future, it may be developed into a gene therapy for neurological and psychiatric disorders involving hyper- active brain, such as epilepsy, schizophrenia, anxiety and autism spectrum disorder. The NIRW-GAD protein will be engineered using the homodimeric bacteriophytochrome engineering approach, where bacteriophyto- chromes are a class of photoreceptors that sense light within the NIRW spectrum. In Aim 1, the NIRW-GAD prototypes will be designed and screened for light-inducible GAD activity in yeast. The dynamic range and back- ground activity of the enzyme will be optimized using mutagenesis. In Aim 2, we will examine the NIRW-GAD expression and the effects of NIRW treatment in the somatosensory cortex neurons of mice. We will also quantify the effect of NIRW-GAD on GABAergic synapses and GABA quantal content in cortical neurons in vitro. Upon completion of this project, we expect to have engineered and tested a unique optogenetic tool for noninvasive control of the major inhibitory neurotransmitter in silencing of neuronal activity in mammals. 0
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Delaying cognitive decline in mouse models of Alzheimer's disease via near-infrared light optogenetics
  • 批准号:
    10392484
  • 项目类别:
  • 资助金额:
    $18.06万
  • 财政年份:
    2021
  • 负责人:
    Mark Gomelsky
  • 依托单位:
Cyclic di-GMP-dependent regulation of metabolism and virulence in Borrelia burgdorferi
Cyclic di-GMP-dependent regulation of metabolism and virulence in Borrelia burgdorferi
Bacteriophytochrome-based optogenetic tools for mammalian gene regulation
  • 批准号:
    8684960
  • 项目类别:
  • 资助金额:
    $20.98万
  • 财政年份:
    2014
  • 负责人:
    Mark Gomelsky
  • 依托单位:
海外基金